To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05872204
Title Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer (ALEPRO)
Acronym ALEPRO
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Universitaire Ziekenhuizen KU Leuven
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | FRA | BEL

Facility Status City State Zip Country Details
UZ Gent RECRUITING Gent Oost-Vlaanderen 9000 Belgium Details
UZ Leuven RECRUITING Leuven Vlaams-Brabant 3000 Belgium Details
CHU de Liège RECRUITING Liège 4000 Belgium Details
Institut De Cancerologie Strasbourg Europe RECRUITING Strasbourg Bas-Rhin 67200 France Details
Institut Bergonie RECRUITING Bordeaux Gironde 33000 France Details
Institut Universitaire Du Cancer Toulouse-Oncopole RECRUITING Toulouse Haute-Garonne 31059 France Details
Institut De Cancerologie De L'Ouest RECRUITING Saint-Herblain Loire-Atlantique 44800 France Details
Centre Leon Berard RECRUITING Lyon Métropole de Lyon 69008 France Details
Groupe Hospitalier Diaconesses Croix Saint Simon RECRUITING Paris Île-de-France 75020 France Details
Erasmus Medical Center Rotterdam RECRUITING Rotterdam South Holland 3015 GD Netherlands Details
University Medical Center Groningen NOT_YET_RECRUITING Groningen 9713 GZ Netherlands Details
University Medical Center Utrecht NOT_YET_RECRUITING Utrecht 3584 CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field